Inpatient treatment for severe atopic dermatitis in a Traditional Korean Medicine hospital: Introduction and retrospective chart review

AbstractThe aim of this study was to examine involuntary medication in psychiatric inpatient treatment. A retrospective chart review of 1543 consecutive admissions of working aged civil patients from well-defined catchment areas to three psychiatric centres were evaluated regarding events of involuntary medication. 8.2% of the admissions included involuntary medication episode(s). Involuntary medication was associated with a diagnosis of schizophrenia, involuntary legal status and having previously been committed. One of the studied centres used less involuntary medication than the other two, even if patients with schizophrenia were over-represented in that centre. Although involuntary medication mainly takes places in the treatment of patients who are conceptualised most ill and perhaps resist treatment most, treatment culture obviously also plays a role. In future, it is important to study the aspects of treatment culture to fully understand the use of involuntary medication in psychiatry.

Download Full-text

A study on the Development of Traditional Korean Medicine Clinical Practice Guideline for Atopic Dermatitis

The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology ◽

10.6114/jkood.2012.25.2.038 ◽

2012 ◽

Vol 25 (2) ◽

pp. 38-48 ◽

Cited By ~ 7

Author(s):

Young-Hee Yun ◽

In-Hwa Choi

Keyword(s):

Atopic Dermatitis ◽

Clinical Practice ◽

Clinical Practice Guideline ◽

Practice Guideline ◽

Traditional Korean Medicine ◽

Korean Medicine

Download Full-text

Transient Hypogammaglobulinemia and Severe Atopic Dermatitis: Open-label Treatment with Immunoglobulin in a Case Series

Allergy & Rhinology ◽

10.2500/ar.2016.7.0164 ◽

2016 ◽

Vol 7 (2) ◽

pp. ar.2016.7.0164 ◽

Cited By ~ 4

Author(s):

Moira E. Breslin ◽

Joanna H. Lin ◽

Robert Roberts ◽

Kellie J. Lim ◽

E. Richard Stiehm

Keyword(s):

Atopic Dermatitis ◽

Los Angeles ◽

Intravenous Immunoglobulin ◽

Conventional Therapy ◽

Case Series ◽

Retrospective Chart Review ◽

Immunoglobulin Therapy ◽

Severe Atopic Dermatitis ◽

Open Label ◽

Intravenous Immunoglobulin Therapy

Background We reported on six infants between 5 and 11 months old, with transient hypogammaglobulinemia of infancy and severe refractory atopic dermatitis, who were treated with open-label immunoglobulin (Ig) after conventional therapy failed. All six infants had an IgG level of <225 mg/dL, elevated eosinophil and IgE levels, and no urine or stool protein losses, but they did exhibit hypoalbuminemia. Objective To evaluate the utility of open-label immunoglobulin in infants with severe atopic dermatitis for whom conventional therapy failed. We reviewed the clinical utility of intravenous immunoglobulin in the treatment of severe atopic dermatitis, the most recent research in the field, and suggested mechanisms for its benefit. Methods The six infants were identified from a retrospective chart review at the University of California Los Angeles Allergy and Immunology outpatient pediatric clinic. Results All six patients were treated with 400 mg/kg/month of intravenous immunoglobulin and had normalization of their IgG and albumin levels, and all but one had clinically improved atopic dermatitis. Conclusion Infants with severe atopic dermatitis who did not respond to conventional therapy avoidance may benefit from intravenous immunoglobulin therapy.

Download Full-text